Clinical Trials Therapeutics AI in Medicine Targeted Therapy Biotechnology Targeted Therapies Disease Modeling Phase 3 Trials AI in Healthcare New Treatments Cancer Treatment Neurological Disorders Protein Biology Breakthroughs Antiviral Drugs Gout Treatment Disease Treatment FDA Regulations Synthetic Proteins Molecular Biology Inflammatory Diseases Cancer Research Therapeutic Response Innovative Treatments Disease Mechanisms Protein Interactions Antibiotics Pharmaceuticals Combination Therapy Regulatory Approval Protein-based Drugs Nanotechnology DNA-Encoded Chemical Libraries Photopharmacology Clinical Guidelines Investigational Therapies Cardiotoxicity Testing Chemical Reactions Aduhelm Efficacy Testing Methods Structural Biology Antiparasitic Drugs Viral Inactivation Anti-Aging Treatments Protein Targets Vaccine Targets Oncology Vaccine Research Protein-Based Therapies Monoclonal Antibodies Life-saving Drugs Protein Structure Prediction Therapeutic Options Ophthalmic Solutions Research Methodologies Clinical Testing Vaccines Therapeutic Design
The pact backs Parabilis’ Helicon peptides to reach protein targets inside cells once seen as out of reach.
